SEC Form 4 · accession 0001780030-26-000004
Faeth Therapeutics, Inc. · FTH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Brian C Stephenson
Officer — Chief Financial Officer
Period of report
Jun 22, 2026
Accepted (ET)
Jun 24, 2026 · 6:58 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001829802
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Jun 22, 2026 | P | 1,797 | $20.23 | A | 1,797 | I | See footnote |
| Common StockF3,F2 | Jun 22, 2026 | P | 1,118 | $20.82 | A | 2,915 | I | See footnote |
| Common StockF4,F2 | Jun 22, 2026 | P | 1,583 | $22.40 | A | 4,498 | I | See footnote |
| Common StockF5,F2 | Jun 22, 2026 | P | 3,329 | $23.28 | A | 7,827 | I | See footnote |
| Common StockF6,F2 | Jun 22, 2026 | P | 356 | $23.95 | A | 8,183 | I | See footnote |
| Common StockF7,F2 | Jun 23, 2026 | P | 6,836 | $24.12 | A | 15,019 | I | See footnote |
| Common StockF8,F2 | Jun 23, 2026 | P | 1,969 | $24.84 | A | 16,988 | I | See footnote |
| Common StockF9,F2 | Jun 23, 2026 | P | 425 | $25.91 | A | 17,413 | I | See footnote |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $19.5765 to $20.545, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.
- F2These shares are held directly by the Brian Stephenson Revocable Trust (the "Trust"), of which the Reporting Person is the sole trustee and has sole voting and investment power over all securities owned by the Trust. The Reporting Person disclaims beneficial ownership of the shares except to the extent of his pecuniary interest therein.
- F3The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $20.62 to $21.17, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.
- F4The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $21.79 to $22.7733, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.
- F5The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $22.8003 to $23.69, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.
- F6The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $23.82 to $24.04, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.
- F7The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $23.62 to $24.59, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.
- F8The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $24.64 to $25.57, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.
- F9The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $25.64 to $26.31, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.